Alprostadil CAS 745-65-3
Identification
Properties
Safety Data
Specifications & Other Information
Links
Identification
CAS Number
745-65-3
Name
Alprostadil
Synonyms
(-)-Prostaglandin E1
(11a,13E,15S)-11,15-Dihydroxy-9-oxo-prost-13-en-1-oic acid
(11a,13E,15S)-11,15-Dihydroxy-9-oxoprost-13-en-1-oic Acid
(11α,13E,15S)-11,15-Dihydroxy-9-oxoprost-13-en-1-oic acid [ACD/IUPAC Name]
(11α,13E,15S)-11,15-Dihydroxy-9-oxoprost-13-en-1-säure [German] [ACD/IUPAC Name]
(1R,2R,3R)-3-Hydroxy-2-((E)-(3S)-3-hydroxy-1-octenyl)-5-oxocyclopentaneheptanoic acid
212-017-2 [EINECS]
7-{(1R,2R,3R)-3-hydroxy-2-[(1E,3S)-3-hydroxyoct-1-en-1-yl]-5-oxocyclopentyl}heptanoic acid
7-{(1R,2R,3R)-3-Hydroxy-2-[(1E,3S)-3-hydroxyoct-1-en-1-yl]-5-oxocyclopentyl}heptansäure [German]
Acide (11α,13E,15S)-11,15-dihydroxy-9-oxoprost-13-én-1-oïque [French] [ACD/IUPAC Name]
acide 7-{(1R,2R,3R)-3-hydroxy-2-[(1E,3S)-3-hydroxyoct-1-én-1-yl]-5-oxocyclopentyl}heptanoïque [French]
Alprostadil [USAN] [Wiki]
Alprostadil Prostoglandin E1
alprostadilum [Latin] [INN]
Caverject [Wiki]
Prost-13-en-1-oic acid, 11,15-dihydroxy-9-oxo-, (11α,13E,15S)- [ACD/Index Name]
Prostaglandin E1
Prostaglandine E
(-)-3-hydroxy-2-(3-hydroxy-1-octenyl)-5-oxo-Cyclopentaneheptanoate
(-)-3-hydroxy-2-(3-hydroxy-1-octenyl)-5-oxo-Cyclopentaneheptanoic acid
(11α,13E,15S)-11,15-Dihydroxy-9-oxoprost-13-enoic acid
(11α,13E,15S)-11,15-DIHYDROXY-9-OXOPROST-13-ENOIC ACID
(13E)-(15S)-11,15-dihydroxy-9-oxoprost-13-enoate
(13E)-(15S)-11,15-dihydroxy-9-oxoprost-13-enoic acid
(13E)-(15S)-11-α,15-dihydroxy-9-oxoprost-13-enoate
(13E)-(15S)-11α,15-Dihydroxy-9-oxoprost-13-enoate
(13e)-(15S)-11α,15-dihydroxy-9-oxoprost-13-enoic acid
(13E)-(15S)-11-α,15-dihydroxy-9-oxoprost-13-enoic acid
(13E,15S)-11α,15-dihydroxy-9-oxoprost-13-en-1-oic acid
11,15-Dihydroxy-9-oxoprost-13-en-1-oate [ACD/IUPAC Name]
11,15-dihydroxy-9-oxoprost-13-en-1-oic acid (ACD/Name 4.0)
119314-69-1 [RN]
11α,15α-dihydroxy-9-oxo-13-trans-prostenoic acid
2061617 [Beilstein]
3-Hydroxy-2-(3-hydroxy-1-octenyl)-5-oxo-cyclopentaneheptanoate
3-Hydroxy-2-(3-hydroxy-1-octenyl)-5-oxocyclopentaneheptanoic acid
3-Hydroxy-2-(3-hydroxy-1-octenyl)-5-oxo-cyclopentaneheptanoic acid
7-((1R,2R,3R)-3-hydroxy-2-((S,E)-3-hydroxyoct-1-en-1-yl)-5-oxocyclopentyl)heptanoic acid
7-((1R,2R,3R)-3-hydroxy-2-((S,E)-3-hydroxyoct-1-enyl)-5-oxocyclopentyl)heptanoic acid
7-[(1R,2R,3R)-3-hydroxy-2-[(1E,3S)-3-hydroxyoct-1-en-1-yl]-5-oxocyclopentyl]heptanoic acid
7-[(1R,2R,3R)-3-hydroxy-2-[(3S)-3-hydroxyoct-1-enyl]-5-keto-cyclopentyl]enanthic acid
7-[(1R,2R,3R)-3-hydroxy-2-[(3S)-3-hydroxyoct-1-enyl]-5-oxocyclopentyl]heptanoic acid
7-[(1R,2R,3R)-3-hydroxy-2-[(3S)-3-hydroxyoct-1-enyl]-5-oxo-cyclopentyl]heptanoic acid
7-[(1R,2R,3R)-3-hydroxy-2-[(E,3S)-3-hydroxyoct-1-enyl]-5-keto-cyclopentyl]enanthic acid
7-[(1R,2R,3R)-3-hydroxy-2-[(E,3S)-3-hydroxyoct-1-enyl]-5-oxocyclopentyl]heptanoic acid
7-[(1R,2R,3R)-3-hydroxy-2-[(E,3S)-3-hydroxyoct-1-enyl]-5-oxo-cyclopentyl]heptanoic acid
7-[5-((1E)(3S)-3-hydroxyoct-1-enyl)(1R,4R,5R)-4-hydroxy-2-oxocyclopentyl]heptanoic acid
745-65-3 [RN]
9-oxo-11?,15S-dihydroxy-prost-13E-en-1-oic acid
9-oxo-11R,15S-dihydroxy-13E-prostaenoic acid
9-oxo-11α,15S-dihydroxy-prost-13E-en-1-oic acid
9-Oxo-11α,15S-dihydroxyprost-13E-en-1-oic acid
Alista
Alprostadil (JP15/USP/INN)
Alprostadil®
Alprostadil®|MR-256|prostaglandin E1
Alprostadilum
Alprox-TD
Befar
Befar; Caverject; Edex; Muse; Prostin VR
BPBio1_001293
BSPBio_001175
BSPBio_001488
Caverject impulse
cGMP Alprostadil
Edex
FemLife
Femprox
GY4569800
IDI1_033958
Liple
Lipoprost
Liprostin
l-Prostaglandin E1
MFCD00077860 [MDL number]
Minprog
MLS000758964
Muse
NCGC00025234-02
NCGC00025234-03
PGE1
PGE1
PGE-1
PGE1 | Prostaglandin E1 |
Prestwick2_001018
Prestwick3_001018
Prink
Prost-13-en-1-oic acid, 11,15-dihydroxy-9-oxo-, (11a,13E,15S)-
Prost-13-en-1-oic acid, 11,15-dihydroxy-9-oxo-, (11α,13E,15S)-, homopolymer
prostaglandin E1
Prostaglandin E1; PGE1
Prostaglandin E1;Edex;Muse;Liprostin;Caverject
ProstaglandinE1
Prostandin
Prostavasin
Prostin VR
Prostin VR pediatric (TN)
Prostivas
SMP2_000271
SMR000112594
Sugiran
Topiglan
Toxic solid, organic, n.o.s. (Alprostadil)
UN 2811
UN2811
UNII-F5TD010360
Viridal
Molecular Structure
SMILES
CCCCC[C@@H](/C=C/[[email protected]]1[C@@H](CC(=O)[C@@H]1CCCCCCC(=O)O)O)O
StdInChI
InChI=1S/C20H34O5/c1-2-3-6-9-15(21)12-13-17-16(18(22)14-19(17)23)10-7-4-5-8-11-20(24)25/h12-13,15-17,19,21,23H,2-11,14H2,1H3,(H,24,25)/b13-12+/t15-,16+,17+,19+/m0/s1
StdInChIKey
GMVPRGQOIOIIMI-DWKJAMRDSA-N
Molecular Formula
C20H33O5
Molecular Weight
353.4736
EINECS
212-017-2
Beilstein Registry Number
5294062
MDL Number
MFCD00077860
Properties
Appearance
White or pale yellow needles
Melting Point
115～116℃
Flash Point
103 °C
Safety Data
Symbol
GHS06, GHS08Signal Word
Danger
Hazard Statements
Precautionary Statements
Personal Protective Equipment
dust mask type N95 (US), Eyeshields, Faceshields, Gloves
RIDADR
UN 2811 6.1 / PGIII
RTECS
GY4569800
Specifications and Other Information of Our Alprostadil CAS 745-65-3
Standard
EP9.2
Identification Methods
HNMR/HPLC
Assay
95%~102%
Specific Optical Rotation
-70°~ -61.6°
Water
0.5%max
Residue on Ignition
0.5%max
Related substance/h3>Impurity A
1.5%max
Impurity B
0.5%max
Any other impurity
0.9%max
Impurity number
1%max
Total Impurities
1.5%max
Residual solvents
Ethanol
5000ppm max
Acetone
5000ppm max
Dichloromethane
600ppm max
n-Hexane
290ppm max
Ethyl acetate
5000ppm max
n-Heptane
5000ppm max
Storage
Stored at 2-8 ° for long time, sealed and away from light.
Application
Commonly used in diabetic neuropathy, myocardial infarction, thrombotic vasculitis, arteriosclerosis obliterans, central retinal vein thrombosis.
Links
Caming Pharmaceutical Ltd
This product is developed by our sub R&D company Caming Pharmaceutical Ltd, and please click the link below for details.
http://www.caming.com/alprostadil-cas-745-65-3/
Watson International Ltd
This product is sold exclusively through our sales company Watson International Ltd, and please click the link below for details.
http://www.watson-int.com/alprostadil-cas-745-65-3/
